MWM
CBAY

Moran Wealth Management’s Cymabay Therapeutics CBAY Stock Holding History

Moran Wealth Management’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-22,246
Closed -$525K – 454
2023
Q4 		$525K Buy
+22,246
New +$396K 0.02% 335

Other funds holding CBAY

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Moran Wealth Management's CBAY Position: Q1 2024 in Review

Moran Wealth Management sold out of Cymabay Therapeutics (CBAY) in Q1 2024, closing a stake of 22,246 shares — an estimated $525K sold.

Moran Wealth Management first reported a position in CBAY in Q4 2023 and held it in 1 quarter. The position peaked at $525K in Q4 2023. 1 fund tracked by Wall St. Rank holds CBAY as of Q1 2024.

  • Moran Wealth Management reported no remaining Cymabay Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Moran Wealth Management sold 22,246 Cymabay Therapeutics shares in Q1 2024, an estimated $525K.
  • Moran Wealth Management first reported a position in Cymabay Therapeutics in Q4 2023 and held it in 1 quarter.
  • Moran Wealth Management's Cymabay Therapeutics position peaked at $525K in Q4 2023.
  • 1 fund tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2024.

Based on Moran Wealth Management's 13F filing for Q1 2024, filed 15 May 2024.